222 - CHALLENGES IN ENDOCARDITIS: A JOB FOR THE MULTIDISCIPLINARY TEAM

Friday, October 25, 2024

9:45 AM – 10:45 AM PT

Room: 116-117

Workshop Description: The management of endocarditis has become increasingly complex. Current society guidelines unequivocally recommend the management of endocarditis through Multidisciplinary Endocarditis Heart Teams, comprised of imaging cardiologists, electrophysiologists, infectious disease specialists, cardiac surgeons, addiction medicine specialists, and nursing experts. However, very few centers across Canada have a dedicated multidisciplinary team that includes all necessary specialists.

This workshop emphasises two key components: (1) modern challenges in endocarditis (IDU within an opioid epidemic, infections of cardiac implantable devices, and the use of partial oral antibiotic therapy); and (2) how solutions are well-integrated in a multidisciplinary team. Speakers will draw upon their own experiences to speak about the challenges and successes of starting and managing their own Endocarditis Heart Team to encourage all centers across Canada to establish teams of their own.

The goal of this workshop is to foster a collaborative environment for all specialists involved in the management of infective endocarditis and to help create a North American consortium of Endocarditis Heart Teams.

Interactive and Engagement Activities Description: This session will begin with live polling to identify priorities/challenges in management in endocarditis in Canadian clinical practice and end with a panel discussion and Q&A period.

Learning Objectives:

At the end of this session participants will be able to:

identify contemporary challenges in infective endocarditis and contemporary and use novel diagnostic and therapeutic strategies to overcome these challenges;
recognize the importance of collaborative interdisciplinary networks to build and share knowledge about infective endocarditis; and
develop practical strategies to implement an Endocarditis Heart Team at their home institution.

Disclosure(s):

Lawrence Lau, MD: No financial relationships to disclose

David Messika-Zeitoun, MD, PhD, FESC: Edwards lifesciences: Research grant (Ongoing)

Corey Adams, MD MSc FRCSC: Corcym: Peer to peer program (Ongoing); Edwards life sciences: Consulting (Ongoing); Medtronic: Peer to peer program (Ongoing)

Sami El-Dalati, MD: No financial relationships to disclose

Mehrdad Golian, MD: No financial relationships to disclose

Victoria Weaver, MD: No financial relationships to disclose

Chair(s)

Lawrence Lau, MD

Cardiologist
University of Ottawa
University of Ottawa Heart Institute

Co-Chair(s)

DM

David Messika-Zeitoun, MD, PhD, FESC

Cardiologist
University of Ottawa Heart Institute
University of Ottawa Heart Institute

Presenter(s)

CA

Corey Adams, MD MSc FRCSC

Cardiac Surgeon
University of Calgary
UNIVERSITY OF CALGARY
SC

Simone Cowan, MD, MSc, BScPhm

Heart Failure and General Cardiologist
St. Paul's Hospital, University of British Columbia
University of British Columbia
Sami El-Dalati, MD

Infectious Diseases, Director of Multidisciplinary Endocarditis Heart Team at University of Kentucky
No
University of Kentucky
Mehrdad Golian, MD

MD
University of Ottawa

Planning Committee Member(s)

FA

Francois Auclair, MD

Infectious Diseases
No
University of Ottawa
Lisa A. Bromley, MD (she/her/hers)

Substance Use Program, Medical Director
No
University of Ottawa
TB

Thomas Brothers, MD PhD

Internal Medicine and Addictions Medicine
No
Amy Charlebois, RN, BScN, MScN

Advanced Practice Nurse (Cardiac Surgery)
University of Ottawa Heart Institute
RC

Ruth Coulton, RN

Clinical Research Nurse Coordinator
University of Ottawa
PD

Piroze Davierwala, MD

Cardiac Surgeon
University of Toronto
Victoria Weaver, MD

Addictions Medicine, Infectious Diseases
No
University of British Columbia